Outcome of the 2024 MPP General Assembly

Apr 29, 2024

The Medtech & Pharma Platform (MPP) Association held its annual General Assembly meeting on 29 April 2024.

MPP Association members reviewed activities in 2023 and highlights for 2024, with a view to enhance synergies between the pharma, medtech, diagnostic and tech sectors to develop and improve access to health technologies. The MPP President underlined the progress work achieved by the association as a recognized stakeholder in the field of combined products. which is now a recognized stakeholder at the European level. She thanked the members for their support, which has enabled the MPP to continuously expand its activities and presence.

The General Assembly elected the following candidates for the MPP Board of Directors: Shayesteh Fürst-Ladani as President, Stephan Affolter (Ypsomed), Daniel Delfosse (Swiss Medtech), Stephanie Horn (Roche), Manfred Mäder (Novartis), Fanny Barbotin (BD), and Ruth Foster (MSD). Shayesteh Fürst-Ladani was re-elected as President.

The MPP Association will pursue its efforts in 2024 to bridge the pharma, medtech, diagnostic, and tech sectors and to progress toward a sustainable regulatory framework for combined products in Europe by working together with relevant stakeholders and regulators.